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Background: Many branches of biomedical research find use for pure recombinant proteins for direct application
or to study other molecules and pathways. Glutathione affinity purification is commonly used to isolate and purify
glutathione S-transferase (GST)-tagged fusion proteins from total cellular proteins in lysates. Although GST affinity
materials are commercially available as glutathione immobilized on beaded agarose resins, few simple options for
in-house production of those systems exist. Herein, we describe a novel method for the purification of GST-tagged
recombinant proteins.
Results: Glutathione was conjugated to low molecular weight poly(ethylene glycol) diacrylate (PEGDA) via thiol-ene
“click” chemistry. With our in-house prepared PEGDA:glutathione (PEGDA:GSH) homogenates, we were able to
purify a glutathione S-transferase (GST) green fluorescent protein (GFP) fusion protein (GST-GFP) from the soluble
fraction of E. coli lysate. Further, microspheres were formed from the PEGDA:GSH hydrogels and improved protein
binding to a level comparable to purchased GSH-agarose beads.
Conclusions: GSH containing polymers might find use as in-house methods of protein purification. They exhibited
similar ability to purify GST tagged proteins as purchased GSH agarose beads.
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Recombinant DNA and protein technologies have taken
a leading role in many forms of research over the past
40 years [1]. Recombinant proteins have found their way
to the core of most biomedical research. Classical meth-
ods of protein purification can be divided into methods
that utilize chemical properties of the protein including
solubility [2], physical characteristics, e.g. isoelectric
points and size [3], and those that use selective endogen-
ous or engineered [4] protein affinity. Of this latter cat-
egory, fusion proteins have emerged as a prominent
method for purification. Fusion proteins are created by
appending a full length or truncated protein to a ter-
minal region of the protein of interest. For affinity fusion* Correspondence: rag@uic.edu
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reproduction in any medium, provided the orproteins, the appended protein will bind to a third, typ-
ically small, molecule that is immobilized on the surface
of a polymer resin. The fusion protein will selectively
bind to the surface while other proteins are washed away
[5]. In column chromatography methods, protein lysates
are eluted through columns that are packed with poly-
mer particles. Alternatively, the affinity matrix can be
mixed directly with the protein lysates, agitated for some
amount of time, centrifuged and collected in batch selec-
tion methods. Fusion proteins are genetically tagged
with a protein of known affinity. The glutathione
S-transferase (GST)-protein is frequently used to tag a
protein of interest because of its affinity for the reduced
form of the tripeptide, glutathione [6]. During the elu-
tion process, excess glutathione is added to remove the
tagged protein from the affinity matrix.
Traditionally, glutathione is covalently linked to the
surface of activated agarose beads (SepharoseW). A thiol
bond is formed between the glutathione and an alipathic
spacer that is linked to a hydroxyl group on the surfaceal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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glutathione as a capture agent for GST fusion proteins,
almost all scientific supply companies carry a variation
of glutathione conjugated polymeric beads, and at least
one patent has been awarded [8] for its utility in pro-
teins. Agarose has been widely used for glutathione con-
jugation. The chemistry of this linkage has multiple
reaction and purification steps that restrict in-house pro-
duction of these beads to chemistry laboratories [4,7].
Thiol-ene “click” chemistry has been shown to reprodu-
cibly form covalent thioether bonds between thiol and
alkene-containing molecules. Glutathione (GSH) has been
covalently linked to alkene groups in poly (N-isopropyl
acrylamide) (PNIPAm) polymers [9]. While glutathione
linkage to PNIPAm was confirmed, a detailed validation
of the interaction with GST tagged proteins was not
presented.
Using a modified form of thiol-ene chemistry and
readily available materials, we demonstrate a simple,
one-step method for creating gel homogenates and
beads with affinity toward GST tagged proteins. Specific-
ally, our method employs thiol-ene addition of glutathi-
one to low molecular weight poly(ethylene glycol)
diacrylate (PEGDA). Under standard conditions, the
resulting polymer forms hydrogels with typical radical
initiators. These gels were readily homogenized, washed,
and used to purify soluble GST proteins. In our proof of
concept study, GST-fused, red shifted green fluorescent
protein (rsGFP) was purified with PEGDA:GSH homoge-
nates. We also demonstrate a novel method for creating
glutathione-laden PEGDA microspheres using reverse-
phase emulsion polymerization. Like the homogenates,
PEGDA:GSH microspheres exhibited affinity to GST-GFP
and can be used to purify the protein. Either of these
methods can be implemented in almost any laboratory
using readily available, inexpensive reagents.
Results and discussion
Challenging economic times combined with the influx of
new scientists in biomedical research makes funding op-
portunities less frequent and resources increasingly
strained. In response to these environmental pressures,
scientists must adapt by using any available resources as
tools for discovery. Newer, cheaper methods will replace
traditionally more expensive techniques. Although many
kits are available, most of these kits have substantial
mark-up that is not always combined with quality.
To create a low-cost approach using widely available
laboratory chemicals for purifying GST tagged proteins,
we have utilized thiol-ene addition of reduced glutathi-
one to low molecular weight PEGDA. We chose to look
predominately at homogenization of gels as a batch puri-
fication method because most laboratories have access
to plastic eppendorf homogenizers or similar. Thissimple method was shown to be reproducible and effect-
ive. We further develop a more complex method that
has more uniformity and compares well with commer-
cially available GST affinity beads.
Creation of vectors & protein expression
To create a model protein for purification, we chose to
use the GFP for its solubility and ease of visualization
[10]. The vector, pET 15b (Figure 1A-1), was con-
structed by inserting a flexible spacer sequence, a hexa-
histadine tag and thrombin cleavable sequence
(Figure 1B, top). The sequence was isolated by PCR
(Figure 1A-2) and cloned into pGEX 6p-1 adjacent to
the GST sequence (Figure 1A-3). GFP was isolated
from gWIZ-GFP by PCR that added a separate spacer
region and a second hexa-histadine tag (Figure 1A-4).
GFP was inserted into the pGEX vector for expression
(Figure 1A-5 & 6). The second hexa-histadine tag of
the protein was not utilized in these experiments, but
is relevant and must be noted because Ni-NTA was
used to purify the GST-GFP for several of the experi-
ments being discussed. The effect of dual hexa-
histadine tags had on purification of the GST-GFP
protein was not analyzed. It is clear that these dual tags
did not negatively impact the protein activity (fluores-
cence) or binding capability to GSH. Resulting colonies
were screened for gross fluorescence of the colonies
(Figure 1C, top) and sequenced. GST-GFP was readily
observed (Figure 1C, lower panel) and purified with a
yield of approximately 300 mg/L of culture (data not
shown). The nickel purified protein fraction was run
on a SDS-PAGE gel to confirm size and thrombin clea-
vability (Figure 1D). The functionality of GST-GFP pro-
tein was confirmed by its increased affinity to nickel
(data not shown) and glutathione beads, its green color
and fluorescence, and its cleavability by thrombin. With
our model protein produced and validated, we pro-
ceeded to validate the purification process.
Affinity of GST-GFP to hydrogel homogenates
Hydrogels were made as described with varying PEGDA
to GSH ratios, and the gels were homogenized, washed,
and incubated with 60 μg of GST-GFP for 2 h. When
purified protein was incubated with the gels (Figure 2), a
significant decrease in GST-GFP was found in the solu-
tion after two hours compared to gel-free controls in the
1:1 (p = 0.008), 5:1 (p = 0.005), 20:1 (p = 0.02), 40:1
(p = 0.02), and 80:1 (p = 0.02) PEGDA to glutathione
ratio gels (Figure 2A). There was clear increase in bound
purified GST-GFP protein (p = 0.00002; Figure 2B) when
GSH was incorporated in the gels at the highest extent.
The 1:1 and 5:1 ratio gels were statistically different from
all other groups while the lower incorporation ratios did
not associate with significantly differing amounts of
Figure 1 Cloning and purification of GST-GFP. A: Schematic of vector construction. (1) A spacer was cloned into the pET 15b vector/plasmid
in proximity to the hexa-histadine tag and thrombin site, pJB-HTS (2) This fragment was cloned from the pET 15b vector (3) into the pGex-6p-1
vector to add a GST upstream, pJB-GST-HTS. (4) Red shifted GFP was isolated by primer extension with a spacer and a second hexa-histadine tag
and (6) cloned into pJB-GST-HTS yielding pJB-GST-HTS-HS-GFP. B: Gel electrophoresis screening of DNA prepared from colonies following step
1—pJB-HTS—were digested with BglII/HindIII (top) the loss of a 500 bp band (lane 1) and appearance of a 318 bp digestion fragment indicates
positive colony for spacer insertion. Arrows indicates 500 bp and 250 bp bands on marker. DNA was digested with NcoI (bottom) to screen for
positive insertions. One was chosen for sequencing and further cloning (asterisk). C: Basal GFP expression of a pJB-GST-HTS-HS-GFP containing
colony is observed microscopically (brightfield overlaid with epifluorescence) with the scale bar indicating 100 μm. After induction, bacteria
express significant green color under UV illumination (bottom) indicating high levels of GFP expression. D: GST-GFP electrophoresed as predicted
for the known molecular weight (2) before and (3) after cleavage with thrombin as compared to the (1) molecular weight ladder with arrows
indicating 55 kDa, 35 kDa, 25 kDa, respectively.
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protein association with gel homogenates harboring
GSH compared to controls. As the PEGDA:GSH ratio
decreased, more GST-GFP was able to associate with the
homogenized gels.
After homogenization and washing, PEGDA:GSH
homogenates were used to specifically purify GST tagged
GFP. Further, we demonstrated that decreasing the
PEGDA:GSH ratio from 80:1 to 1:1 resulted in increased
GST affinity to gel homogenates. The PEGDA:GSH ratio
was not further optimized because GSH inhibitspolymerization reactions and gel formation at higher
concentration. GSH is a known radical scavenger that
decreases the number of free radicals available to sustain
the polymerization cycle [11]. GSH also incorporates
into acrylate groups and stops chain growth by eliminat-
ing alkene groups necessary for polymer propagation [9].
At some point the PEGDA:GSH ratio will become low
enough that no usable gel will form. In this report, we
focused on gels that had qualitatively acceptable and
manageable physical properties, i.e. handlability for
homogenization.
Figure 2 Affinity of GST-GFP to PEGDA:GSH homogenates.
A: Influence of varying PEGDA:GSH ratio on binding of protein as
expressed by the amount (μg) of protein in solution following 2 h
incubation in the presence of PEGDA-GSH hydrogel homogenate
(blue bars) or matched GSH-free PEGDA hydrogel (red bars). B: Influence
of PEGDA:GSH ratio on specifically bound, or incorporated, GST-GFP as
expressed as percent total GST. Total protein (100%) was 60 μg GST-GFP
for all groups. † for p< 0.05, †† for p<0.01, and ††† for p<0.001. Bars
and points represent the mean of 3 independents samples plus or
minus (±) standard deviation.
Figure 3 Elution and Binding of PEGDA:GSH compared to
PEGDA:Cys. A: Gross fluorescence observation of the gels
confirmed GST-GFP association with homogenates prepared with
PEGDA:GSH ratio (top) or equimolar PEGDA:Cys (bottom). B: Gross
fluorescence observation of the gels confirmed PEGDA:GSH
homogenates eluted with either 10 mM cysteine (bottom) or
10 mM GSH (top). C: SDS PAGE electrophoresis confirmed that
minimal protein eluted from (lanes 1–3) PEGDA gels eluted with
GSH, (lanes 4–6) PEGDA:Cys gels eluted with GSH, but protein did
elute (lanes 7–9) from PEGDA:GSH gels eluted with GSH. The last
lane is a protein ladder, arrows indicating 100 kDa, and 55 kDa.
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homogenates
To confirm the specificity of the interaction, nickel-
purified GST-GFP was incubated in the presences of
homogenates made with equimolar GSH (Figure 3A,
top) or cysteine (Figure 3A, bottom). There was noappreciable GFP observed in the cysteine-containing gels
while the GSH-containing gels were visibly fluorescent.
For homogenates made with glutathione, 10 mM GSH
(Figure 3B, top) was able to elute the GFP completely
while 10 mM cysteine (Figure 3B, bottom) was unable to
elute the protein. Elution of the GST-GFP was found to
be specific to GSH. No protein was eluted with GSH
(Figure 3C, lanes 1–3) from hydrogels lacking GSH in-
corporation or eluted by cysteine (Cys; Figure 3C, lanes
4–6) from gels including glutathione. Proteins of appro-
priate molecular weight (Figure 3C, lanes 7–9) were
eluted with GSH from GSH-containing gels.
Purifying GST-GFP from E Coli protein extract
These experiments indicate that specific interactions
take place between the gels and GST fusion proteins.
This is not necessarily indicative of the ability of the
materials to purify proteins from total bacterial lysates.
Using the homogenized 5:1 PEGDA:GSH gels, crude
lysates including GST-GFP from the induced, soluble
protein fraction was batch selected over 2 h and eluted
with 10 mM GSH. From soluble lysate, it was difficult to
elucidate the GST-GFP protein (Figure 4A, lane 1). Fol-
lowing nickel purification (Figure 4A, lanes 2 and 3), the
enriched fraction showed a high degree of purity and ap-
propriate size as a monomer in absence of glutathione
(lane 2) or as a dimer in the presence of glutathione
Figure 4 SDS-PAGE of eluted and purified GST-GFP. A: SDS
PAGE image of proteins obtained from (lane 1) crude soluble lysate,
(lane 2) after Ni purification, (lane 3) Ni purification in the presence
of 10 mM glutathione, (lane 4) purification with PEGDA gel
homogenate, and (lane 5) purified with PEGDA:GSH homogenate.
Blue arrows indicate 100 kDa and 55 kDa while the green and red
arrows are the proposed GST-GFP monomer and dimer, respectively.
B: Protein recovered from PEGDA or PEGDA:GSH gel homogenates
calibrated to total protein concentration from lanes 4 and 5 of
panel. Data is presented the mean plus or minus (±) standard
deviation.
Figure 5 Microscopy of homogenates and beads. Microscopy
and comparison to GSH-Agarose beads. A: Brightfield and
epifluorescence microscopy of homogenates made with PEGDA (top
row) or 5:1 PEGDA:GSH molar ratio (bottom row). B. Brightfield and
fluorescence microscopy of microspheres made with PEGDA (top
row) and PEGDA:GSH (bottom row) at a 5:1 molar ratio. Scale bars
represent 100 μm.
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no purification was achieved with PEGDA gels
(Figure 4A, lane 4). A significant single predominant
band was obtained when purification took place in the
presence of PEGDA:GSH gels (Figure 4A, lane 5). The
size of nickel purified GST-GFP eluted with imidazole
(Figure 4A, green arrow) is half the size of GST-GFPeluted with glutathione (Figure 4A, red arrow). A pro-
tein of this mass is present in all samples and being
twice of the size of the GST-containing monomer sug-
gests dimerization. The absence of the GST monomer
with excess GSH further suggests that the dimer would
be the predominant protein present. It is known that the
GST acts as a homodimer with its substrate between the
two monomers [12]. From 1 mL of the initial soluble
GST-GSH lysate associated with the PEGDA:GSH
homogenates, 0.8 μg were eluted from the PEGDA
homogenates, and 15 μg were eluted from the PEGDA:
GSH homogenates. This indicates an approximate 20
fold increased affinity of the GST-GFP to 5:1 PEGDA:
GSH compared to PEGDA.
The homogenates were examined with fluorescence
microscopy (Figure 5A) and it was noted that the areas
of fluorescence differed in intensity inversely correlating
with the thickness of the homogenized piece. Further,
there was expected variation between the size of the
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500 μm (data not shown). Although we felt the
homogenization method may be acceptable for labs with
the facilities to make the particles and that these experi-
ments allowed us to optimize the parameters necessary
for protein purification, we felt that further improve-
ments were possible. In order to improve the yield of
GSH:PEGDA purified protein and consistency, we
sought more homogeneously distributed, smaller parti-
cles as we expected these to allow for more efficient as-
sociation of GST-GFP to the hydrogels.
Creation of PEGDA:GSH microspheres and establishing
affinity to GST-GFP
We prepared microspheres using a reverse phase emul-
sion technique [13] to obtain more control over size and
shape of the particles. The spheres were more homoge-
nously distributed between 10 μm and 200 μm (Figure 5).
In addition, spheres made with 5:1 PEGDA:GSH showed
significant and uniform association with the GST-GFP
(Figure 5B). Microspheres made from PEGDA:GSH had
significantly greater affinity than PEGDA microspheres.
In addition, there was no significant decrease in affinity
to GST-GFP than purchased spheres made from GSH-
agarose (Figure 6; P = 0.157, one tailed student’s t-test).
We hypothesized that homogenous sized, spherical
microspheres would increase GST-GFP association with
the hydrogels by increasing the surface area of the poly-
mer available for protein association. Microspheres were
produced with PEGDA:GSH ratios as low as 5:1, but
yields decreased at lower ratios (data not shown).Figure 6 GST-GFP association to PEGDA:GSH homogenates and
PEGDA:GSH microspheres. Protein association to GSH-agarose
beads and 5:1 PEGDA:GSH microspheres. Data represent the mean
plus or minus (+/−) standard error of the mean (SEM).Spheres at a 5:1 PEGDA:GSH molar ratio displayed sig-
nificant interaction with GST-GFP over control gels
without GSH. These easy to fabricate and inexpensive
particles have great potential for protein purification.
This is particularly true since the microspheres interact
similarly to purchased GSH-SepharoseW beads. Homoge-
nates were able to remove 35% of the GST-GFP from
the protein solution (Figure 2B) while microspheres bind
a similar amount of GST-GFP (Figure 6) at 10 fold less
mass. Microspheres demonstrate an increased binding
capability compared to the homogenates. This increased
binding may well be attributed to an increased surface
area of the microspheres compared to homogenates, but
further experiments would be needed to test this
hypothesis.
Association of protein through GST-GSH interactions
on the surface PEGDA microspheres introduces the ex-
citing possibility of using these spheres for delivery of
protein therapies. Building upon our previous work using
proteolytically activated hydrogels [14-19], we envision
using fusion proteins to release therapeutic proteins in
response to disease-specific proteases. Therapeutic pro-
teins would be released in the interstitial space [14] or
intracellularly [20] by specific protease sites engineered
between the GST and the therapeutic protein. Alterna-
tively, high intracellular concentrations of reduced gluta-
thione [21] could be used elute the GST-protein from the
glutathione-containing material. Several proteases, in-
cluding matrix metalloproteainse 2 (MMP-2), have been
shown to be upregulated in many cancers [22,23]. Spe-
cific, short amino acid sequences have been discovered
that are cleavable by MMP-2 [24-26], and could be
incorporated between a tag GST and a therapeutic
protein. In this way, the GST-GSH interaction could
act as an anchor, holding the therapeutic protein on a
hydrogel until MMP-2 cleaves the therapeutic protein
from the GST anchor. Such an approach would be
comparable to natural protein release from the extra-
cellular matrix by MMPs. This biomimetic approach
would advance the ability to bind protein therapeutics
to hydrogels for disease-specific release. Further studies
are underway to assess the potential for such a system
in drug delivery.Conclusions
We have shown a simple and effective method for con-
jugating glutathione to PEGDA. These materials specific-
ally purify GST-tagged GFP. The purity of the GFP is
similar to that purified by commercial Ni-affinity agar-
ose, and the purity and yield are compatible to pur-
chased GST-Agarose beads. In challenging economic
times we believe this simple and inexpensive method
will be useful as an in-house alternative to purchasing
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All cloning was done in DH5alpha E. Coli cells and all
vectors confer ampicillin resistance. The vector for
protein production, pJB-GST-HTS-HS-GFP, was cre-
ated by first cloning a 7 amino acid spacer fragment
containing an XhoI site into pET-15b (Novagen) using
sticky ligation and BamHI/XhoI sites. Colonies were
mini-prepped by conventional SDS-precipitation and
screened by BglII/HindIII (New England Biolabs; NEB)
digestion (Figure 1B, lower panel), and confirmed by
subsequent sequencing (ACGT). Primers were designed
to fit in resulting vector, pJB-HTS upstream of the
hexa-histadine tag (5/phos/CCATGGGCAGCAGC
CATCATCAT), and downstream (AGCTGGAATTCC
TAGTTATTGCTCAGCGGTGGC) (Integrated DNA
technologies) of the spacer yielding a fragment con-
taining a phosphorylated 5’ end, an initiation codon, a
hexa-histadine tag, a thrombin cleavable sequence, a
spacer, a termination codon, and an EcoRI site. This
fragment was digested with EcoRI (NEB) and ligated
into pGex-6p1 (GE Healthcare) prepared by digestion
with BamHI and blunting with Mung Bean Nuclease
(NEB) to generate pJB-GST-HTS. Correct insertion
yields a novel NcoI site generated by ligation of the
blunted ends, and so NcoI (NEB) linearization of the
supercoiled vector was used to determine correct inser-
tion (Figure 1b, lower panel). These clones were con-
firmed by DNA sequencing. Primers were designed to
clone rsGFP from gWIZ-GFP (Aldevron) and extending
a BamHI site, a hexa-histadine tag, another spacer re-
gion, the GFP, and an EcoRI site. pJB-GST-HTS and




GTACAGTTCATCCATGCCATG). Colonies were screened
under UV microscopy for basal expression of GFP
(Figure 1c). DNA was sequenced from positive colonies
containing the final product, pJB-GST-HTS-HS-GFP.
Protein expression/Purification
The vector, pJB-GST-HTS-HS-GFP was transformed
into BL21 expression cells for expression and purifica-
tion of GST-GFP protein. Protein was induced with
1 mM IPTG after cells reached an absorbance of 0.5 at
595 nm. They were removed to 25°C and were shaken
overnight. Cells were spun at 4°C for 20 min to pellet,
and resuspended in lysis buffer (50 mM NaH2PO4,
300 mM NaCl, 10 mM imidazole, pH= 8). The suspen-
sion was freeze-thawed 3x at −80°C, sonicated 3x 15 sthen spun at 12 k RPM for 30 min to pellet the insoluble
material. The supernatants were removed and selected
through a gravity flow nickel column containing 1 mL of
NTA Ni Agarose (Qiagen). After repeated washing the
bound fraction was eluted with 250 mM imidazole
(Fischer) in lysis buffer containing 10% glycerol (Acros).
SDS-PAGE/Agarose gel electrophoresis
All gels in this manuscript are 15% w/v SDS PAGE gels
made in-house with 37.5:1 acrylamide:bis (chemicals from
sigma). Samples were prepared with Laemmeli sample
buffer, and loaded into BioRad mini-protean II electro-
phoresis system at 150v until dye ran to end. Agarose
gels were all 1.5% w/v agarose stained with ethidium
bromide (Fischer) and imaged on BioRad GelDoc imager.
Bradford assays
Bradford assay was either purchased from Pierce or made
in-house as described by Bradford 1972 [27]. Absorbances
were routinely read 15 min after sample addition to G-
250. Homogenates were 50 mg to 100 mg wet weight.
Microspheres were 5 mg to 10 mg wet weight. Each data
set included BSA standards, and all protein concentrations
were generated by individual BSA standard curve.
Hydrogel homogenate production/protein binding
Hydrogels were made by adding 150 μL PEGDA
(MW 575, Sigma Aldrich) to varying concentrations of
glutathione (Sigma Aldrich, Alfa Aesar) and 0.05% w/v
Irgacure 2959 (Ciba). PBS was used to bring total
volumes to 1 mL. The tubes were cured overnight under
a UV light (purchased from a local hardware store,
0.25 mW/cm2 254 nm, measured on UVX radiometer).
Gels were homogenized with a polypropylene EPPI-pestle
homogenizer in the eppendorf tube for 10 to 20s at
room temperature until most of the homogenate pieces
were small enough to pass through a 1 mL micropip-
ette tip. These homogenates were then washed with
10 mL PBS in scintillation vials (at least 5 buffer
changes over two days).
Microsphere production
Microspheres were produced by a modified reverse
emulsion polymerization method [13]. Polymer solu-
tion contained 300 μL PEGDA (d= 1.1 g/mL, Sigma),
600 μL PBS, 5 μL eosin Y. Polymer solution (100μL)
was transferred to glass test tube (1.5 mm diameter,
10 mm length) and 4 mL of mineral oil was added.
The tube was vortexed 10s until the polymer solution
formed an emulsion in the oil. Ammonium persulfate
(100 μL, 20%, Sigma) was added while vortexing and
continued for 1 min. Tetramethyl ethylene diamine
(100 μL, 100%, TEMED, Acros) was added and vor-
texing continued for another minute. The tube was
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eral milliliters of deionized water were added. After
most of the microspheres have settled into the aque-
ous phase (several minutes), oil was removed from the
test tube and the solution containing the microspheres
was collected in an eppendorf tube. They were then
spun down, removed of their supernatant, and resus-
pended and washed with several changes of PBS, then
washed over night in 5 mL PBS. Microspheres were
compared to Glutathione Agarose purchased from
Gold Biotechnology.
Microscopy
Brightfield and fluorescence microscopy were carried out
on an Olympus IX70 inverted microscope. Micrographs
were captured on a Q-imaging Retiga 1300 CCD camera.
Statistical analysis
Statistical analysis was done using one tailed students t-
test for pair wise comparison or ANOVA followed by
post-hoc Tukey test for multiple sample comparisons.
Significance was set at α less than or equal to 0.05. Each
experiment was independently repeated three times and
data is presented as mean plus or minus standard devi-
ation unless otherwise noted.
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